Company Monitoring Page for Amgen

latest headlines for company on cafepharma

Amgen's Epogen: Can This Blockbuster Drug Keep Shining?
Motley Fool
Mon, 10/29/12 - 11:40 am
Tags:
anemia, Amgen, Epogen
Amgen 3rd quarter profit higher, raises 2012 forecast
Reuters
Tue, 10/23/12 - 04:50 pm
Tags:
Amgen, earnings
Amgen Earnings Sneak Peek
Wall Street Cheat Street
Sun, 10/21/12 - 10:52 am
Tags:
Amgen, earnings
Amgen's Soaring, but Will Gravity Kick In?
Motley Fool
Sat, 10/20/12 - 10:26 am
Tags:
Amgen
Amgen Third Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Thu, 10/18/12 - 01:06 pm
Tags:
earnings, Amgen
Can Ampio's New Science Take A Big Bite Out Of The $60 Billion Anti-Inflammatory Market?
Seeking Alpha
Thu, 10/18/12 - 11:37 am
Tags:
Ampio, Humira, Remicade, Enbrel, Celebrex, anti-inflammatories, Abbott Labs, Amgen, Ampion, JNJ, Pfizer
3 Things to Watch With Celldex Therapeutics
Motley Fool
Thu, 10/4/12 - 10:52 am
Tags:
Celldex, rindopepimut, CDX-011, Pfizer, Bristol-Myers Squibb, Amgen, Seattle Genetics
Another Approval for Amgen's Prolia
Yahoo/Zacks
Tue, 09/25/12 - 04:45 pm
Tags:
Amgen, Prolia, Merck, Eli Lilly, osteoporosis
Amgen Inc: Today's Featured Health Care Laggard
The Street
Sat, 09/15/12 - 09:29 am
Tags:
Amgen
Amgen drops after analyst says sales of key drug may disappoint Street
Yahoo/The Fly On The Wall
Sat, 09/15/12 - 09:17 am
Tags:
Amgen
Zalicus Misses Key Secondary Endpoint
Seeking Alpha
Mon, 09/10/12 - 01:40 pm
Tags:
Zalicus, Amgen, Novartis, Sanofi, Synavive, rheumatoid arthritis
Amgen Joins Renault Selling Bonds to Pre-Empt Crisis Woes
Bloomberg
Mon, 09/10/12 - 10:49 am
Tags:
Renault, Amgen, bonds
Why Analysts Love Teva
Seeking Alpha
Mon, 09/10/12 - 10:47 am
Tags:
Amgen, JNJ, Teva Pharmaceuticals, Merck, Pfizer, Watson Pharmaceuticals
Amgen Inc: Today's Featured Drugs Laggard
The Street
Sat, 09/8/12 - 10:43 am
Tags:
Amgen
Ampio's New Anti-Inflammatory Drug May Achieve Rapid FDA Clearance
Seeking Alpha
Wed, 09/5/12 - 06:53 pm
Tags:
Ampio, FDA, Abbott Labs, JNJ, Amgen, Pfizer, Ampion, osteoarthritis
A Good Start on the Biosimilar Front
Motley Fool
Tue, 09/4/12 - 11:04 am
Tags:
biosimilars, Teva Pharmaceuticals, Amgen, Watson Pharmaceuticals, Momenta, Baxter International, FDA, Affordable Care Act
2012 Biotech Stock Predictions: An Interim Report Card
TheStreet.com
Tue, 08/28/12 - 11:07 am
Tags:
Cell Therapeutics, Momenta, Onyx, Amag Pharmaceuticals, Biomarin, M&A, Celgene, Seattle Genetics, Galena Biopharma, ImmunoCellular, Amgen, Celldex, Dendreon, GSK, Vical, Oncothyreon, Biogen Idec, Merck KGaA, Bristol-Myers Squibb, Allos, Spectrum Pharmaceuticals, AstraZeneca
Healthcare Sector Undervalued, 3 Stocks With Mixed Upside
Motley Fool
Sat, 08/25/12 - 11:32 am
Tags:
Bristol-Myers Squibb, Amgen, Baxter
Amgen Doing Fine Despite Challenges
Investors.com
Wed, 08/22/12 - 11:04 am
Tags:
Amgen
Amgen: When Buybacks Work
Seeking Alpha
Sun, 08/19/12 - 11:33 am
Tags:
Amgen

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.